Development Of An Inhibitor For A New Therapeutic Target (Hit To Lead)

  Address - France

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 110742070

  Document Type - Tender Notices

Description - Description: We seek to develop an inhibitor against a newly identified therapeutic target in our laboratory.Our focus will be on a chemical series derived from HTS screening, which has subsequentlybeen optimized during a hit expansion phase. This re quest for proposal (RFP) concerns a hitto-lead optimization phase, which is expected to last for six months. The goal is to strengthenthe structure-activity relationship (SAR) of our chemical series.local title:: Développement d'un inhibiteur pour une nouvelle cible thérapeutique (Hit to lead)Contract Duration: : 120 DAYContract Type: : Servicelocal description: : We seek to develop an inhibitor against a newly identified therapeutic target in

Gt Ref Id - 110742070

Deadline - Jul 07, 2025